Literature DB >> 26927827

[Clear cell sarcoma of kidney in children].

Hélène Sudour-Bonnange1, Frédérique Dijoud2, Marc-David Leclair3, Nathalie Rocourt4, Christophe Bergeron5.   

Abstract

Clear cell sarcoma of the kidney (CCSK) is a rare tumor that is diagnosed most often in children between 2- and 4-years-old of age. Usually, patients with CCSK are treated in international study for intrarenal tumors, preferentially Wilms tumor, according to bad histopronostic group. The purpose of this paper is to review the most important features in 2015 about epidemiology, radiology, anatomopathology and genetic of CCSK, and above all a synthesis about successive treatment strategies with their results. Second most common pediatric renal tumor in children less than 5-years-old, its prognosis has improved dramatically in recent years with the use of anthracyclines.
Copyright © 2016 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anthracycline; Children; Clear cell sarcoma of kidney; Enfant; Renal tumor; Sarcomes cellules claires; Tumeurs rénales

Mesh:

Substances:

Year:  2016        PMID: 26927827     DOI: 10.1016/j.bulcan.2016.01.017

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  3 in total

1.  Clear cell sarcoma of the kidney in children: a clinopathologic analysis of three cases.

Authors:  Shaohua Chen; Ming Li; Ran Li; Jintao Cao; Qiong Wu; Ting Zhou; Zhaogen Cai; Nan Li
Journal:  Int J Clin Exp Pathol       Date:  2020-04-01

Review 2.  Clear cell sarcoma of the kidney with inferior vena cava thrombus: a case report.

Authors:  Leen Jamel Doya; Khaled Alyousef; Majdy Oukan; Ali Razzok; Basel Shek Alshabab; Tarek AlEid; Rabab Saloum; Hassan Nasser
Journal:  J Med Case Rep       Date:  2022-08-01

3.  Overall survival nomogram and relapse-related factors of clear cell sarcoma of the kidney: A study based on published patients.

Authors:  Yuan Zhang; Qian Chu; Yue Ma; Chunshu Miao; Juan-Juan Diao
Journal:  Front Pediatr       Date:  2022-09-16       Impact factor: 3.569

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.